RU2012148602A - METHOD FOR INTEGRATED EVALUATION OF INDICATIONS FOR PURPOSE OF CARDIOMETABOLIC THERAPY IN INFECTIOUS DISEASES - Google Patents
METHOD FOR INTEGRATED EVALUATION OF INDICATIONS FOR PURPOSE OF CARDIOMETABOLIC THERAPY IN INFECTIOUS DISEASES Download PDFInfo
- Publication number
- RU2012148602A RU2012148602A RU2012148602/14A RU2012148602A RU2012148602A RU 2012148602 A RU2012148602 A RU 2012148602A RU 2012148602/14 A RU2012148602/14 A RU 2012148602/14A RU 2012148602 A RU2012148602 A RU 2012148602A RU 2012148602 A RU2012148602 A RU 2012148602A
- Authority
- RU
- Russia
- Prior art keywords
- points
- point
- cardiometabolic
- indicators
- therapy
- Prior art date
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
1. Способ оценки показаний к кардиометаболической терапии при инфекционных поражениях миокарда у детей, заключающийся в выявлении и количественной оценке клинических, электрокардиографических, биохимических и эхокардиографических показателей, каждый из которых оценивают от 1 до 3 баллов, баллы суммируют и по полученному результату осуществляют оценку показания к кардиометаболической терапии, при общей сумме меньше 3 баллов кардиометаболическая терапия не показана, при общей сумме от 3 баллов до 7 баллов включительно назначают пероральное применение кардиометаболических препаратов, при общей сумме от 8 баллов и выше назначают парентеральное введение кардиометаболических препаратов.2. Способ по п.1, отличающийся тем, что в качестве клинических показателей оценивают аускультативную симптоматику: звучность тонов, наличие шумов; показатели артериального давления.3. Способ по п.1, отличающийся тем, что в качестве биохимических показателей оценивают активность кардиоспецифичных ферментов: МВ-фракции креатинфосфокиназы, α-гидрокисбутиратдегидрогеназы, аспарагиновой трансаминазы, аланиновой трансаминазы) и кардиоспецифичного белка тропонина I.4. Способ по п.1, отличающийся тем, что эхокардиографическое исследование осуществляют с применением допплерографии для оценки диастолической функции желудочков.5. Способ по п.1, отличающийся тем, что клинические, электрокардиографические, биохимические и эхокардиографические показатели оценивают в баллах, а именноприглушенность или глухость тонов - 1 балл,систолический и/или диастолический шум - 1 балл,тахикардия или брадикардия, не соответствующие фазе заболевания - 1. A method for assessing indications for cardiometabolic therapy for infectious myocardial lesions in children, which consists in identifying and quantifying clinical, electrocardiographic, biochemical and echocardiographic indicators, each of which is evaluated from 1 to 3 points, the scores are summarized and, according to the result, the indications for cardiometabolic therapy, with a total amount of less than 3 points, cardiometabolic therapy is not indicated, with a total amount of 3 points to 7 points inclusive, oral administration of cardiometabolic drugs is prescribed, with a total amount of 8 points or more, parenteral administration of cardiometabolic drugs is prescribed. The method according to claim 1, characterized in that auscultatory symptoms are evaluated as clinical indicators: sonority of tones, the presence of noise; indicators of arterial pressure.3. The method according to claim 1, characterized in that the activity of cardiospecific enzymes is evaluated as biochemical indicators: MB-fraction of creatine phosphokinase, α-hydrokisbutyrate dehydrogenase, aspartic transaminase, alanine transaminase) and cardiospecific troponin protein I.4. The method according to claim 1, characterized in that the echocardiographic study is carried out using Doppler ultrasound to assess the diastolic function of the ventricles. The method according to claim 1, characterized in that clinical, electrocardiographic, biochemical and echocardiographic indicators are evaluated in points, namely, muffled or dull tones - 1 point, systolic and / or diastolic noise - 1 point, tachycardia or bradycardia that do not correspond to the phase of the disease -
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012148602/14A RU2539990C2 (en) | 2012-11-15 | 2012-11-15 | Method of complex evaluation of indications for administration of cardiometabolic therapy in case of infectious diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012148602/14A RU2539990C2 (en) | 2012-11-15 | 2012-11-15 | Method of complex evaluation of indications for administration of cardiometabolic therapy in case of infectious diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2012148602A true RU2012148602A (en) | 2014-05-20 |
RU2539990C2 RU2539990C2 (en) | 2015-01-27 |
Family
ID=50695632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012148602/14A RU2539990C2 (en) | 2012-11-15 | 2012-11-15 | Method of complex evaluation of indications for administration of cardiometabolic therapy in case of infectious diseases |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2539990C2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2714178C2 (en) * | 2017-09-27 | 2020-02-12 | Татьяна Александровна Руженцова | Method for assessing risk of adverse outcomes of infectious myocardial injuries in children and adolescents |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10507009B2 (en) | 2017-10-05 | 2019-12-17 | EchoNous, Inc. | System and method for fusing ultrasound with additional signals |
AU2019356470A1 (en) | 2018-10-08 | 2021-05-13 | EchoNous, Inc. | Device including ultrasound, auscultation, and ambient noise sensors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2181564C2 (en) * | 1998-12-15 | 2002-04-27 | Новокузнецкий государственный институт усовершенствования врачей | Method for making metabolism correction within the framework of intensive care complex for treating hypovolemic shock |
UA67227U (en) * | 2011-07-05 | 2012-02-10 | Алексей Маркович Давиденко | method for prognostication of the course of acute infectious myocarditis in children |
-
2012
- 2012-11-15 RU RU2012148602/14A patent/RU2539990C2/en active IP Right Revival
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2714178C2 (en) * | 2017-09-27 | 2020-02-12 | Татьяна Александровна Руженцова | Method for assessing risk of adverse outcomes of infectious myocardial injuries in children and adolescents |
Also Published As
Publication number | Publication date |
---|---|
RU2539990C2 (en) | 2015-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Corrado et al. | Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria | |
Calò et al. | Echocardiographic findings in 2261 peri-pubertal athletes with or without inverted T waves at electrocardiogram | |
Rizzo et al. | Left ventricular function, cardiac dysrhythmias, atrial activation, and volumes in nondipper hypertensive individuals with left ventricular hypertrophy | |
Sugawara et al. | Impact of chronic exercise training on the blood pressure response to orthostatic stimulation | |
RU2012148602A (en) | METHOD FOR INTEGRATED EVALUATION OF INDICATIONS FOR PURPOSE OF CARDIOMETABOLIC THERAPY IN INFECTIOUS DISEASES | |
Ragazzoni et al. | How to evaluate resting ECG and imaging in children practising sport: a critical review and proposal of an algorithm for ECG interpretation | |
Okoye et al. | Electrocardiographic abnormalities in treatment-naïve HIV subjects in south-east Nigeria | |
Demir | Left ventricular systolic and diastolic function in subjects with a bicuspid aortic valve without significant valvular dysfunction | |
Tadic et al. | The association between heart rate variability and biatrial phasic function in arterial hypertension | |
Lee et al. | Effects of atrial fibrillation on arterial stiffness in patients with hypertension | |
Tsiberkin et al. | Hypokalemia in hospitalized patients with pneumonia associated with COVID-19 | |
Demir et al. | Effect of hepatitis C virus infection on the right ventricular functions, pulmonary arterypressure and pulmonary vascular resistance | |
Lind et al. | Lifetime change in central and peripheral haemodynamics in relation to exercise capacity | |
Nedogoda et al. | Achievement of target blood pressure in patients with arterial hypertension on the background of antihypertensive therapy in real clinical practice | |
Morka et al. | Left ventricular diastolic dysfunction assessed by conventional echocardiography and spectral tissue doppler imaging in adolescents with arterial hypertension | |
Barbarash et al. | Diagnosis of latent forms of non-coronary atherosclerosis in acute coronary syndrome patients. Is there any practical sense? | |
Vdovenko et al. | The myocardial deformation and diastolic function of the left ventricle in patients with heart failure with preserved left ventricular ejection fraction | |
Speranza et al. | Adult ECG criteria for left ventricular hypertrophy in young competitive athletes | |
Gorshunova et al. | ASSOCIATION OF HYPERTENSIVE ENDOTHELIAL DYSFUNCTION WITH THE SEVERITY OF MYOCARDIAL DYSFUNCTION AND CHRONIC HEART FAILURE IN ELDERLY PATIENTS | |
Hsiao | Left atrial expansion index is associated with recurrent stroke | |
RH Allam et al. | CARDIOVASCULAR EFFECTS OF ORAL ANTIVIRAL TREATMENT FOR NON-CARDIAC HCV PATIENTS | |
Nemes et al. | Is there a relationship between increased aortic stiffness and segmental left ventricular deformation in elite athletes?(Insights from the MAGYAR-Sport Study) | |
ADEBIYI et al. | Left ventricular geometry and electrocardiographic criteria in assessing left ventricular hypertrophy in sickle cell anemia patients | |
Gunay et al. | Left Atrial Mechanical Function And Stiffness In Patients With Premature Ventricular Contraction: A Speckle Tracking Study | |
El-Dosouky et al. | Types and predictors of interferon/ribavirin induced cardiac complications in the egyptian patients with chronic hepatitis C virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20151116 |
|
NF4A | Reinstatement of patent |
Effective date: 20170321 |
|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20181116 |
|
NF4A | Reinstatement of patent |
Effective date: 20200217 |
|
HE4A | Change of address of a patent owner |
Effective date: 20200824 |